AvantiCell Science was founded in June 2006 and with over 13 years working in primary cell culture, we have a wealth of experience to share with researchers looking to add predictive value to their research.

Based in the west coast of Scotland, our team deliver cell-based solutions using advanced cell culture technology based on physiologically-relevant human and animal primary cells for researchers wishing to evaluate bio-activity or bio-safety of a wide-range of test materials; from pharmaceuticals, traditional medicines and natural products to medical devices and nano-structured materials. 

We supply a growing range of human and animal primary cell products which are accessible as cryopreserved cell isolates requiring re-culture within researcher's laboratories. These primary cells add predictive value to drug discovery research without the hassle and cost of cell isolation. High-quality technical support makes the inclusion of these cell types into a researcher's project straight-forward and efficient.

Our expertise in a wide variety of cell-based services, ranging from simple cell health assays to specialist cell culture systems, can be fully customised to meet researcher's requirements. Custom cell isolations and development of specialised cell models and analytical platforms also offer researcher's the chance to fully optimise their platform before testing of their candidate materials.




Established 2006

AvantiCell was set up by a small group of founding investors and is not a spinout company. AvantiCell private investment is coupled with venture capital investment matched by Scottish Government.

Our Ethical Framework

AvantiCell use of human cells and access to human “surgical excess” tissue adheres to national ethical guidelines and is approved by the West of Scotland Research Ethics Committee.

Our Founding Principle

AvantiCell's founding principle is that advances in cell culture technology enable the development of physiologically-relevant alternatives to animal testing.